Protagonist Therapeutics
PTGX
PTGX
274 hedge funds and large institutions have $3.15B invested in Protagonist Therapeutics in 2025 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 86 increasing their positions, 90 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
274
Holders Change
+34
Holders Change %
+14.17%
% of All Funds
3.72%
Holding in Top 10
14
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+100%
% of All Funds
0.19%
New
72
Increased
86
Reduced
90
Closed
35
Calls
$51.1M
Puts
$31.9M
Net Calls
+$19.2M
Net Calls Change
+$20M
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$96.7M |
| 2 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$35.4M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$32.6M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$16.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$16.3M |
Top Sellers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$72.4M |
| 2 |
JFG
Jefferies Financial Group
New York
|
-$41.5M |
| 3 |
State Street
Boston,
Massachusetts
|
-$30.2M |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$15.1M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$13.5M |
